Clik here to view.
City of Hope and Imugene Announce First Patient Dosed in Phase 1 Trial to...
SYDNEY & LOS ANGELES Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States,...
View ArticleClik here to view.
【日本企業唯一】3歳未満向けの乳幼児用食品に使用が認められたプロバイオティクス※１ 『ビフィズス菌BB536』が中国「新食品原料」に登録※2
東京 （ビジネスワイヤ） – 森永乳業は、森永乳業独自のビフィズス菌である「ビフィズス菌BB536（Bifidobacterium longum BB536）」が、5月11日付けで中国の「新食品原料」に登録されましたことをお知らせいたします。 ※1出典：国家食品安全风险评估中心(China National Center for Food Safety Risk...
View ArticleClik here to view.
New World Group’s Humansa Announces New Strategic Focus
HONG KONG Humansa, a healthcare organization under the New World Group, today announced its new strategic focus as a premium and comprehensive provider of preventative healthcare and wellness...
View ArticleClik here to view.
On Gout Awareness Day, Let’s Put the Myths to Rest
JIANGSU, China Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such...
View ArticleClik here to view.
Propanc Biopharma Undertaking PRP Manufacturing ＆ Development for Human Use
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Xlear与Dr. Ferrer BioPharma合作，向用户提供更佳鼻腔卫生体验
犹他州亚美利加福克 (美国商业资讯)–Xlear今天宣布与Dr. Ferrer BioPharma (DFBP)建立新的伙伴关系，这将使Xlear鼻腔喷雾剂成为首款部署GentleMist喷嘴的鼻腔卫生工具。研究显示，这种新一代鼻腔喷雾剂技术的化合物弥散和覆盖更优、用户体验更佳。...
View ArticleClik here to view.
SCAI 2022 Scientific Meetingで心原性ショックの予後改善に向けたImpellaの研究と進歩を大きく紹介
米マサチューセッツ州ダンバース （ビジネスワイヤ） — 画期的な心臓・肺・腎臓支援技術のリーダー企業であるアビオメッド（NASDAQ: ABMD）は、アトランタで5月19～22日に開催される米国心臓血管造影・インターベンション学会（SCAI）2022 Scientific...
View ArticleClik here to view.
Clik here to view.
New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the American Journal of Emergency Medicine in which Dr. Gülsah Demir and colleagues at...
View ArticleClik here to view.
訂正・差し替え SCAI 2022 Scientific Meeting で心原性ショックの予後改善に向けた Impella の研究と進歩を大きく紹介
米マサチューセッツ州ダンバース （ビジネスワイヤ） — 画期的な心臓・肺・腎臓支援技術のリーダー企業である アビオメッド（NASDAQ: ABMD）は、アトランタで5月19～22日に開催される米国心臓血管造影・インターベンション学会（SCAI）2022 Scientific...
View ArticleClik here to view.
Sermo调查显示，今年ASCO的与会肿瘤学家对新的肺癌和乳腺癌研究最感兴趣
纽约 医生优先的在线社区、全球医疗保健提供者(HCP)洞察领导者Sermo的一项新调查发现，在美国临床肿瘤学会(ASCO)年会期间，近一半(47%)的与会肿瘤学家对肺癌的新数据最感兴趣。紧随其后的是乳腺癌相关新数据，高达44%的受访肿瘤学家表示对此最感兴趣，此外，54%的肿瘤学家/血液学家表示最有兴趣了解肿瘤靶向抗体疗法。...
View ArticleClik here to view.
中智全球寻求与台湾医疗保险公司结成战略联盟，为数百万台湾患者提供服务，确保他们能够远程获得可靠及优质的医疗保健服务。
达拉斯 (美国商业资讯)–中智全球(6819.HK)一直提供SEC³URE Ethos、SEC³URE Passport、Link & GO!、BioBytes™和BioBytes™...
View ArticleClik here to view.
IntelliCentrics Seeks Strategic Alliance With Taiwanese Health Insurance...
DALLAS IntelliCentrics (6819.HK) connects trusted stakeholders across the continuum of care by delivering valuable, technology-enabled services such as the SEC³URE Ethos, SEC³URE Passport, Link...
View ArticleClik here to view.
Genuv Announces Preclinical Data to be Released at Two Medical Conferences in...
SEOUL, South Korea Genuv Inc., a clinical-stage biotechnology company focused on innovative drug discovery for degenerative central nervous system diseases and advanced immuno-oncology therapeutics,...
View ArticleClik here to view.
Pharmaron Acquires Commercial API Manufacturing Facility in the United States
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive Asset Purchase Agreement to acquire the Coventry API...
View ArticleClik here to view.
新研究发现，Masimo PVi®或有助于急诊科医生确定哮喘患儿发作的严重程度
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天公布《美国急诊医学杂志》(American Journal of Emergency Medicine)发表的一项回顾性研究的结果。土耳其伊兹密尔Tepecik研究和培训医院的Gülsah Demir博士及其同事调查了Masimo...
View ArticleClik here to view.
Global Aesthetics Brand Hugel Inc. Accelerates the Leap Forward as a Global...
NEWPORT BEACH, Calif. Hugel Inc., a global medical aesthetics company and South Korea’s leading company in the botulinum toxin and hyaluronic acid fillers market, announced to convene an...
View ArticleClik here to view.
Masimo PVi®がER医による小児患者の喘息発作の重症度判定で役立ち得ることを示す新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、American Journal of Emergency Medicine誌に掲載された後ろ向き研究の結果を発表しました。本試験では、トルコのイズミールにあるテペジキ研究研修病院のGülsah...
View ArticleClik here to view.
IntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital ＆ Clinics’...
DALLAS IntelliCentrics (6819.HK) the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and BioBytes™ Visitor, today announced Advanced Dallas Hospital & Clinics has...
View ArticleClik here to view.
Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to...
SEOUL, South Korea Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet...
View Article